SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-003737
Filing Date
2015-04-21
Accepted
2015-04-21 16:30:02
Documents
12
Period of Report
2015-06-02
Effectiveness Date
2015-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224347zdef14a.htm DEF 14A 513722
2 G931321.JPG g931321.jpg GRAPHIC 17412
3 G17967.JPG g17967.jpg GRAPHIC 12580
4 G805373.JPG g805373.jpg GRAPHIC 367
5 G415536.JPG g415536.jpg GRAPHIC 484
6 G787214.JPG g787214.jpg GRAPHIC 461
7 G884729.JPG g884729.jpg GRAPHIC 39689
8 G757104.JPG g757104.jpg GRAPHIC 34510
9 G243055.JPG g243055.jpg GRAPHIC 13699
10 G81184.JPG g81184.jpg GRAPHIC 46612
11 G94302BCI001.GIF g94302bci001.gif GRAPHIC 61778
12 G94302BCI002.GIF g94302bci002.gif GRAPHIC 48903
  Complete submission text file 0001047469-15-003737.txt   897458
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35060 | Film No.: 15783532
SIC: 2834 Pharmaceutical Preparations